US UDI rule for devices falls further behind schedule
This article was originally published in SRA
The US Food and Drug Administration is now almost three month behind the statutory 19 June deadline by which the agency was meant to release its final rule on establishing a unique device identifier (UDI) system for medical devices.
You may also be interested in...
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.
Oral explanation meetings are due to take place this week for drug sponsors who have a final chance to address questions and concerns the European Medicines Agency has about their marketing applications.
The EU marketing application for cefiderocol that lost fast track status last July is now up for an opinion by the European Medicines Agency.